Related Experiment Videos
Cloning hybridomas in a reversible three-dimensional alginate matrix
1Division of Thoracic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
Hybridoma
|October 1, 1992
Summary
This study introduces a novel alginate-gelatin matrix for efficient hybridoma cloning. This method supports stable monoclonal antibody production in a three-dimensional environment.
Area of Science:
- Biotechnology
- Cell Biology
- Immunology
Background:
- Alginate, a polymer of guluronic and mannuronic acids, offers a biocompatible microenvironment for cell culture.
- Hybridoma technology is crucial for producing monoclonal antibodies, but efficient cloning remains a challenge.
Purpose of the Study:
- To develop a novel three-dimensional alginate matrix for efficient cloning of antibody-producing hybridomas.
- To optimize hybridoma culture conditions for enhanced stability and productivity.
Main Methods:
- Incorporation of 10-15% (v/v) gelatin into alginate prior to gelation to create growth cavities.
- Utilizing the calcium-dependent, temperature-independent alginate gelation process.
- Employing a calcium chelator for matrix reversibility.
Main Results:
- Successfully cloned over 90 monoclonal antibody-producing hybridomas using the alginate matrix.
- Demonstrated efficient cloning in limited incubator space, without feeder layers, and with minimal medium.
- The transparent matrix facilitated easy screening for clonality and growth.
Conclusions:
- The alginate-gelatin matrix provides an effective and versatile platform for hybridoma cloning.
- This technique enhances efficiency and simplifies screening in monoclonal antibody production.
- The method offers a practical solution for laboratories with limited resources.